Articles tagged with: Zidovudine
Headline, News »
Many HIV patients suffer from cognitive dysfunction and memory problems.
In a recent study conducted at the Washington University School of Medicine in St. Louis, researchers have found that HIV-related cognitive impairments are similar to Alzheimer’s related dementia in one aspect – the presence of low levels of the protein amyloid beta in the spinal fluid.
However, the progression towards cognitive dysfunction in HIV patients differs from that in patients with mild Alzheimer’s disease.
According to the researchers, proteins found in the fluid surrounding the brain and…
Headline, News »
On November 6, the Food and Drug Administration (FDA) approved revised dosing recommendations for zidovudine (Retrovir), a major anti-HIV drug used in children.
The update allows for treatment to begin at four weeks of age, as long as children weigh at least 4 kilograms (8 lb 13 oz). Previously the FDA had recommended starting children on zidovudine at six weeks of age.
Zidovudine, also known as azidothymidine (AZT), was the first drug approved for use against HIV in 1987. It is used for treating both adults and children with HIV…